Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 19.4223.813.11

What is the latest EV/Core EBITDA ratio of TRIDENT LIFELINE ?

The latest EV/Core EBITDA ratio of TRIDENT LIFELINE is 19.42 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.42
Mar202323.81
Mar20223.11

How is EV/Core EBITDA of TRIDENT LIFELINE Trending?

Years EV/Core EBITDA % Change
Mar2024 19.42
-18.44
Mar2023 23.81
665.59
Mar2022 3.11 -

Other Financial Ratios of TRIDENT LIFELINE


Compare EV/Core EBITDA ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹286.9 Cr 4.9% -4.9% 33.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,213.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹150,403.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹117,415.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,791.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹92,228.2 Cr -0.9% -10% -11.3% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

4.9%

-4.9%

33.5%

SENSEX

0.4%

-4.9%

-0.1%


You may also like the below Video Courses